Drug intelligence / Profile preview

RSHO-X

Development stage
Preclinical
Lead developer
Medical Marijuana, Inc.
Administration
Oral, Sublingual
01

Overview

**RSHO-X** is a THC-free CBD isolate liquid product developed by HempMeds, a subsidiary of Medical Marijuana, Inc., formulated as pure cannabidiol (CBD) blended with organic medium-chain triglyceride (MCT) oil derived from coconut oil to enhance bioavailability. It contains no detectable THC (<0.1%), making it compliant with strict cannabis regulations and safe for World Anti-Doping Agency standards, suitable for athletes, military personnel, and those subject to drug testing. A 2017 Mexican study by Dr. Saul Garza Morales on 39 children with Lennox-Gastaut syndrome using progressive doses up to 5-7 mg CBD/kg over 4 months reported 84% reduction in motor seizures, 53% with >75% reduction, and 17% with complete seizure elimination, with zero adverse effects—outperforming Epidiolex in efficacy and safety. Available in concentrations like 2500mg or 5000mg CBD per bottle, it is approved for import by Mexico's COFEPRIS as the first cannabis-based product there, and used for epilepsy, anti-inflammatory effects, antioxidant support, pain relief, and general wellness.[1][2][11]

Brand names
RSHO-XReal Scientific Hemp Oil-X
Other names
RSHO-X CBD Oil
02

Targets

CNR1 (Cannabinoid receptor 1)

Beyond the preview

Go deeper on RSHO-X.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RSHO-X.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call